Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival

作者: Jennifer Rubin Grandis , Mona F. Melhem , William E. Gooding , Roger Day , Valerie A. Holst

DOI: 10.1093/JNCI/90.11.824

关键词: Internal medicineLymph nodeOncologyPathologyCarcinomaCancerHead and neck squamous-cell carcinomaEpidermoid carcinomaHead and neck cancerEpidermal growth factorSurvival analysisMedicine

摘要: Background: The most accurate predictor of disease recurrence in patients treated for head and neck squamous cell carcinoma is, at present, the extent regional lymph node metastasis. Since elevated levels epidermal growth factor receptor (EGFR) its ligand, transforming factor-a (TGF-a), have been detected primary tumors with carcinoma, we determined whether tumor these proteins were prognostic importance. Methods: Monoclonal antibodies specific EGFR TGF-a used immunohistochemical detection each protein tissue sections from 91 who by surgical resection. Levels immunoreactive quantified use a computerized image analysis system normalized to appropriate standards. logrank test proportional hazards regression calculate probability that associated disease-free survival (i.e., no cancer) cause-specific do not die their disease). All P values two-sided. Results: When or analyzed as continuous variables, reduced among higher (both = .0001) .0001). In multivariate analysis, site, level EGFR, statistically significant predictors survival; similar stage survival. Conclusion: Quantitation carcinomas may be useful identifying subgroups high risk guiding therapy. [J Natl Cancer Inst 1998; 90:824‐32]

参考文章(61)
Buchler M, Korc M, Kobrin Ms, Yamanaka Y, Friess H, Beger Hg, Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness. Anticancer Research. ,vol. 13, pp. 565- 569 ,(1993)
O Dassonville, J L Formento, M Francoual, A Ramaioli, J Santini, M Schneider, F Demard, G Milano, Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer. Journal of Clinical Oncology. ,vol. 11, pp. 1873- 1878 ,(1993) , 10.1200/JCO.1993.11.10.1873
Hitoshi Niikura, Hironobu Sasano, Gen Matsunaga, Keiko Watanabe, Kiyoshi Ito, Shinji Sato, Akira Yajima, Prognostic value of epidermal growth factor receptor expression in endometrioid endometrial carcinoma Human Pathology. ,vol. 26, pp. 892- 896 ,(1995) , 10.1016/0046-8177(95)90013-6
C. Soon Lee, Anna Redshaw, Guy Boag, TGF-alpha immunoreactivity in laryngeal carcinoma: lack of prognostic value and correlation to EGF-receptor expression. Australian and New Zealand Journal of Surgery. ,vol. 66, pp. 464- 468 ,(1996) , 10.1111/J.1445-2197.1996.TB00783.X
B GUSTERSON, G COWLEY, J SMITH, B OZANNE, Cellular localisation of human epidermal growth factor receptor. Cell Biology International Reports. ,vol. 8, pp. 649- 658 ,(1984) , 10.1016/0309-1651(84)90045-6
C. Lin, W. Chen, W Kruiger, L. Stolarsky, W Weber, R. Evans, I. Verma, G. Gill, M. Rosenfeld, Expression cloning of human EGF receptor complementary DNA: gene amplification and three related messenger RNA products in A431 cells Science. ,vol. 224, pp. 843- 848 ,(1984) , 10.1126/SCIENCE.6326261
E. L. Kaplan, Paul Meier, Nonparametric Estimation from Incomplete Observations Springer Series in Statistics. ,vol. 53, pp. 319- 337 ,(1992) , 10.1007/978-1-4612-4380-9_25
James G. Booth, P. H. Westfall, S. S. Young, Resampling-Based Multiple Testing. Journal of the American Statistical Association. ,vol. 89, pp. 354- ,(1994) , 10.2307/2291234
Jose Baselga, John Mendelsohn, The epidermal growth factor receptor as a target for therapy in breast carcinoma. Breast Cancer Research and Treatment. ,vol. 29, pp. 127- 138 ,(1994) , 10.1007/BF00666188